Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Empagliflozin
Therapeutic Area : Endocrinology
Study Phase : Phase III
Sponsor : University of Health Sciences Lahore
Deal Size : Inapplicable
Deal Type : Inapplicable
Vitamin D, K2 Plus Empagliflozin Combination in Type Two Diabetes Mellitus
Details : Undisclosed
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
June 14, 2022
Lead Product(s) : Empagliflozin
Therapeutic Area : Endocrinology
Highest Development Status : Phase III
Sponsor : University of Health Sciences Lahore
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Vortioxetine Hydrobromide
Therapeutic Area : Psychiatry/Psychology
Study Phase : Phase III
Sponsor : Rawalpindi Medical College
Deal Size : Inapplicable
Deal Type : Inapplicable
Vortioxetine as a Novel Anti-depressant With Improvement in Cognitive Abilities
Details : Undisclosed
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
November 03, 2021
Lead Product(s) : Vortioxetine Hydrobromide
Therapeutic Area : Psychiatry/Psychology
Highest Development Status : Phase III
Sponsor : Rawalpindi Medical College
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Sunnyd Stat
Therapeutic Area : Nutrition and Weight Loss
Study Phase : Phase II
Sponsor : Rawalpindi Medical College
Deal Size : Inapplicable
Deal Type : Inapplicable
Comparative Pharmacokinetics of Two Different Oral Delivery Systems of Cholecalciferol
Details : Undisclosed
Product Name : Undisclosed
Product Type : Undisclosed
Upfront Cash : Inapplicable
November 03, 2021
Lead Product(s) : Sunnyd Stat
Therapeutic Area : Nutrition and Weight Loss
Highest Development Status : Phase II
Sponsor : Rawalpindi Medical College
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Apixaban
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Phase II
Sponsor : Rawalpindi Medical College
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Undisclosed
Product Name : Undisclosed
Product Type : HPAPI
Upfront Cash : Inapplicable
October 22, 2021
Lead Product(s) : Apixaban
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Phase II
Sponsor : Rawalpindi Medical College
Deal Size : Inapplicable
Deal Type : Inapplicable